These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27677694)

  • 1. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.
    Kajeechiwa L; Thwin MM; Shee PW; Yee NL; Elvina E; Peapah P; Kyawt K; Oo PT; PoWah W; Min JR; Wiladphaingern J; von Seidlein L; Nosten S; Nosten F
    Malar J; 2016 Sep; 15(1):494. PubMed ID: 27677694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
    McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
    Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
    PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos).
    Adhikari B; Phommasone K; Kommarasy P; Soundala X; Souvanthong P; Pongvongsa T; Henriques G; Newton PN; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Mayxay M; Cheah PY; Pell C
    Malar J; 2018 Jan; 17(1):15. PubMed ID: 29316932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey.
    Nguyen TN; Thu PN; Hung NT; Son DH; Tien NT; Van Dung N; Quang HH; Seidlein LV; Cheah PY; Dondorp AM; Day NP; White NJ; Hien TT
    Malar J; 2017 Jan; 16(1):17. PubMed ID: 28061908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
    Pongvongsa T; Phommasone K; Adhikari B; Henriques G; Chotivanich K; Hanboonkunupakarn B; Mukaka M; Peerawaranun P; von Seidlein L; Day NPJ; White NJ; Dondorp AM; Imwong M; Newton PN; Singhasivanon P; Mayxay M; Pukrittayakamee S
    Malar J; 2018 Nov; 17(1):405. PubMed ID: 30390647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
    Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D
    Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study.
    Aung PL; Soe MT; Soe TN; Oo TL; Aung PP; Khin A; Thi A; Phuanukoonnon S; Okanurak K; Cui L; Kyaw MP; Parker DM
    Parasit Vectors; 2021 Oct; 14(1):549. PubMed ID: 34689796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR.
    Adhikari B; Phommasone K; Pongvongsa T; Kommarasy P; Soundala X; Henriques G; White NJ; Day NPJ; Dondorp AM; von Seidlein L; Cheah PY; Pell C; Mayxay M
    Malar J; 2017 Oct; 16(1):424. PubMed ID: 29061133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
    Tripura R; Peto TJ; Chea N; Chan D; Mukaka M; Sirithiranont P; Dhorda M; Promnarate C; Imwong M; von Seidlein L; Duanguppama J; Patumrat K; Huy R; Grobusch MP; Day NPJ; White NJ; Dondorp AM
    Clin Infect Dis; 2018 Aug; 67(6):817-826. PubMed ID: 29522113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
    Mwesigwa J; Achan J; Affara M; Wathuo M; Worwui A; Mohammed NI; Kanuteh F; Prom A; Dierickx S; di Tanna GL; Nwakanma D; Bousema T; Drakeley C; Van Geertruyden JP; D'Alessandro U
    Clin Infect Dis; 2019 Jul; 69(2):278-286. PubMed ID: 30304511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community acceptability, participation, and adherence to mass drug administration with primaquine for Plasmodium vivax elimination in Southern Thailand: a mixed methods approach.
    Saita S; Roobsoong W; Khammaneechan P; Sukchan P; Lawpoolsri S; Sattabongkot J; Cui L; Okanurak K; Phuanukoonnon S; Parker DM
    Malar J; 2023 Jan; 22(1):17. PubMed ID: 36635642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    Morris U; Msellem MI; Mkali H; Islam A; Aydin-Schmidt B; Jovel I; Shija SJ; Khamis M; Ali SM; Hodzic L; Magnusson E; Poirot E; Bennett A; Sachs MC; Tarning J; Mårtensson A; Ali AS; Björkman A
    BMC Med; 2018 Dec; 16(1):215. PubMed ID: 30526588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia.
    Dierickx S; Gryseels C; Mwesigwa J; O'Neill S; Bannister-Tyrell M; Ronse M; Jaiteh F; Gerrets R; D'Alessandro U; Grietens KP
    PLoS One; 2016; 11(2):e0148627. PubMed ID: 26866685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
    Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
    PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.
    Shekalaghe SA; Drakeley C; van den Bosch S; ter Braak R; van den Bijllaardt W; Mwanziva C; Semvua S; Masokoto A; Mosha F; Teelen K; Hermsen R; Okell L; Gosling R; Sauerwein R; Bousema T
    Malar J; 2011 Aug; 10():247. PubMed ID: 21864343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review.
    Adhikari B; James N; Newby G; von Seidlein L; White NJ; Day NP; Dondorp AM; Pell C; Cheah PY
    Malar J; 2016 Nov; 15(1):523. PubMed ID: 27806717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive, self-administered malaria treatment against asymptomatic malaria infection: results of a cluster randomized controlled trial in The Gambia.
    Okebe J; Dabira E; Jaiteh F; Mohammed N; Bradley J; Drammeh NF; Bah A; Masunaga Y; Achan J; Muela Ribera J; Yeung S; Balen J; Peeters Grietens K; D'Alessandro U
    Malar J; 2021 Jun; 20(1):253. PubMed ID: 34098984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.